decisionhealth Newsletters, Part B News - 2016 Issue 2 (February)
Chemo drugs drive volatile average payments for Part B drugs, 2010-2014
Subscribe or sign in to view the full article.
Article Overview
This article examines Medicare Part B drug payment changes over time using claims data and a broad set of J-codes. It is aimed at readers who monitor drug payment trends, Medicare reimbursement patterns, and chemotherapy-related billing issues. The discussion focuses on overall volatility, standout upward and downward payment movements, and the article’s data source and time frame.
Why This Topic Matters
Understanding payment volatility for Part B drugs helps coding, billing, and reimbursement professionals interpret how Medicare drug payments can shift over time and identify broader trends affecting oncology and other injectable therapies.
What You Will Learn
- How Medicare Part B drug payments varied across a multi-year period
- What kinds of drugs showed especially large payment swings
- How claims-data analysis can be used to review payment trends
- Which broad therapeutic categories were highlighted in the discussion
Who Should Read This
- Medical coders
- Billing specialists
- Reimbursement analysts
- Practice administrators
- Oncology billing staff
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com